Advertisement

More articles from Therapeutic Discovery

  • Ligand Systemic Targeting of the Grp78 Promoter
    Azadeh Kia, Justyna M. Przystal, Nastasia Nianiaris, Nicholas D. Mazarakis, Paul J. Mintz, Amin Hajitou
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2566-2577; DOI: 10.1158/1535-7163.MCT-12-0587
  • Sorafenib Targets VCP in Hepatocellular Cancer Cells
    Ping Yi, Arisa Higa, Said Taouji, Mariana G. Bexiga, Esther Marza, Daniela Arma, Claire Castain, Brigitte Le Bail, Jeremy C. Simpson, Jean Rosenbaum, Charles Balabaud, Paulette Bioulac-Sage, Jean-Frédéric Blanc, Eric Chevet
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2610-2620; DOI: 10.1158/1535-7163.MCT-12-0516
  • RSK2 as Therapeutic Target for Myeloma
    Yuji Shimura, Junya Kuroda, Masaki Ri, Hisao Nagoshi, Mio Yamamoto-Sugitani, Tsutomu Kobayashi, Miki Kiyota, Ryuko Nakayama, Shinsuke Mizutani, Yoshiaki Chinen, Natsumi Sakamoto, Yosuke Matsumoto, Shigeo Horiike, Yukimasa Shiotsu, Shinsuke Iida, Masafumi Taniwaki
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2600-2609; DOI: 10.1158/1535-7163.MCT-12-0605
  • Dll4-Fc Suppresses Liver Metastasis of SCLC Cells
    Takuya Kuramoto, Hisatsugu Goto, Atsushi Mitsuhashi, Sho Tabata, Hirohisa Ogawa, Hisanori Uehara, Atsuro Saijo, Soji Kakiuchi, Yoichi Maekawa, Koji Yasutomo, Masaki Hanibuchi, Shin-ichi Akiyama, Saburo Sone, Yasuhiko Nishioka
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2578-2587; DOI: 10.1158/1535-7163.MCT-12-0640
  • miR-200c Sensitizes Ovarian Cancer Xenografts to Paclitaxel
    Diana M. Cittelly, Irina Dimitrova, Erin N. Howe, Dawn R. Cochrane, Annie Jean, Nicole S. Spoelstra, Miriam D. Post, Xian Lu, Russell R. Broaddus, Monique A. Spillman, Jennifer K. Richer
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2556-2565; DOI: 10.1158/1535-7163.MCT-12-0463
  • Novel BMP4 Agonist to Promote Tumor Angiogenesis
    Marijana Miljkovic-Licina, Philippe Hammel, Sarah Garrido-Urbani, Boris P.-L. Lee, Mehdi Meguenani, Chiraz Chaabane, Marie-Luce Bochaton-Piallat, Beat A. Imhof
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2588-2599; DOI: 10.1158/1535-7163.MCT-12-0245
  • Glucocorticoid Receptor Signals in Bladder Cancer Cells
    Yichun Zheng, Koji Izumi, Yi Li, Hitoshi Ishiguro, Hiroshi Miyamoto
    Molecular Cancer Therapeutics Dec 2012, 11 (12) 2621-2632; DOI: 10.1158/1535-7163.MCT-12-0621
  • Ceramide and Tamoxifen in Breast Cancer
    Samy A.F. Morad, Jonathan C. Levin, Sriram S. Shanmugavelandy, Mark Kester, Gemma Fabrias, Carmen Bedia, Myles C. Cabot
    Molecular Cancer Therapeutics Nov 2012, 11 (11) 2352-2361; DOI: 10.1158/1535-7163.MCT-12-0594
  • Wip1 Targeting Resensitizes Cancer Cells to Cisplatin
    Ling Wang, Adam J. Mosel, Gregory G. Oakley, Aimin Peng
    Molecular Cancer Therapeutics Nov 2012, 11 (11) 2401-2409; DOI: 10.1158/1535-7163.MCT-12-0448
  • SLM6, an Anti-Myeloma Agent and CDK9 Inhibitor
    Nathan G. Dolloff, Joshua E. Allen, David T. Dicker, Nicole Aqui, Dan Vogl, Jozef Malysz, Giampaolo Talamo, Wafik S. El-Deiry
    Molecular Cancer Therapeutics Nov 2012, 11 (11) 2321-2330; DOI: 10.1158/1535-7163.MCT-12-0578

Pages